2020 annual financial data

Celldex Therapeutics, Inc. 2020 Operating margin

Celldex Therapeutics, Inc. 2020 operating margin with verified reported values.

Direct answer

Operating margin was -854.06%.

Operating income was -63,354,000 USD and net income was -59,780,000 USD.
Operating cash flow was -40,404,000 USD.

Get free Celldex Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
7,418,000 USD
Operating income
-63,354,000 USD
Net income
-59,780,000 USD
Operating cash flow
-40,404,000 USD